NIH Seeks Comments on Research Data Hub Update
Published Date: 5/27/2026
Notice
Summary
The Eunice Kennedy Shriver National Institute of Child Health and Human Development wants your thoughts on updating their Data and Specimen Hub (DASH), a system that helps researchers share important health data and samples. If you’re involved in health research or data sharing, this affects you! Comments are open until July 27, 2026, and the update aims to make data collection easier without costing extra time or money.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 1 costs, 1 mixed.
Researchers' data submission time burden
If you submit or request data or biospecimens through NICHD DASH, you must register and complete forms that take time. NICHD estimates the total annualized respondent burden is 1,010 hours across all forms, with average per-form times listed: User Registration 5 minutes, Institutional Certification 10 minutes, Data Request Annual Progress Report 30 minutes, Data Request 1 hour, Data and Biospecimen Catalog Submission 2 hours, and Biospecimen Request 1 hour. The package requests OMB approval for 3 years and reports a 6-hour reduction in the annualized burden; comments are due July 27, 2026.
Some recipient details may be published
NICHD may share certain information from data or biospecimen requests publicly: the Recipient's approved use of DASH data/biospecimens, the Recipient's name and institution, and significant findings reported in the Data Request Annual Progress Report. These items may appear on the DASH website or in publications describing DASH performance and value.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-17438, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings in late September 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers applying for funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
Previous / Next Documents
Previous: 2026-10516, Stationary and Portable Air Compressors From the People's Republic of China, Malaysia, and the Socialist Republic of Vietnam: Initiation of Less-Than-Fair-Value Investigations
The U.S. is starting investigations into whether air compressors from China, Malaysia, and Vietnam are being sold unfairly cheap, which could hurt American makers like MAT Industries. If unfair pricing is found, extra taxes might be added to these imports to protect U.S. businesses. This process kicked off on May 20, 2026, and could lead to changes in prices and trade rules soon.
Next: 2026-10518, Notice of OFAC Sanctions Action
The U.S. Treasury’s OFAC just blocked the property of Jesus Alonso Aispuro Felix from Mexico for his role in illegal drug trade and terrorism. This means U.S. people and businesses can’t do any deals with him, and his assets under U.S. control are frozen starting May 20, 2026. It’s a big move to stop bad actors and protect the global community from crime and terror.